Petros Pharmaceuticals, Inc.
PTPI
$0.0919
-$0.0106-10.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.22M | -662.00K | -2.16M | 318.20K | -4.55M |
| Total Depreciation and Amortization | 768.30K | 754.70K | 753.50K | 934.80K | 860.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -143.10K | -1.48M | -1.48M | -5.25M | 1.43M |
| Change in Net Operating Assets | 824.30K | -278.80K | 1.76M | 1.74M | -1.79M |
| Cash from Operations | -771.20K | -1.66M | -1.13M | -2.26M | -4.05M |
| Capital Expenditure | -19.10K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.10K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -385.50K | -379.80K | -- | -374.20K | -368.60K |
| Issuance of Common Stock | -- | -- | -- | 15.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -2.39M | -1.58M | -1.12M | -2.00M | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -15.00M | -- |
| Cash from Financing | -2.77M | -1.96M | -1.12M | -2.37M | 14.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.57M | -3.62M | -2.26M | -4.63M | 10.59M |
